特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
671132

バイオ医薬品発酵システムの世界市場:製品(上流製品、下流製品)、アプリケーション、最終用途別の産業分析、市場規模、シェア、成長率、動向および予測(2018年~2026年)

Biopharmaceutical Fermentation Systems Market (Product - Upstream Products, Downstream Products; Application; End use) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

出版日: | 発行: Transparency Market Research | ページ情報: 英文 254 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
バイオ医薬品発酵システムの世界市場:製品(上流製品、下流製品)、アプリケーション、最終用途別の産業分析、市場規模、シェア、成長率、動向および予測(2018年~2026年)
出版日: 2018年07月18日
発行: Transparency Market Research
ページ情報: 英文 254 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のバイオ医薬品発酵システム市場について分析し、製品の概要や最新の市場情勢、全体的な市場規模の動向見通し 、製品別・アプリケーション別・最終用途別・地域別の詳細動向、主要企業のプロファイル・市場シェアなどを調査しております。

目次

第1章 イントロダクション

  • 市場の定義と範囲
  • 市場セグメンテーション
  • 主な調査目的
  • 調査のハイライト

第2章 前提と調査方法

第3章 エグゼクティブサマリー:世界のバイオ医薬品発酵システム市場

第4章 市場の概要

  • イントロダクション
    • 製品タイプの定義
    • 産業の進化/発展
  • 概要
  • 市場動向
    • 成長要因
    • 阻害要因
    • 市場機会
    • 主要動向
  • 世界のバイオ医薬品発酵システム市場の分析と予測、2016-2026年
    • 市場収益予想(百万USドル)
  • ポーターのファイブフォース分析

第5章 市場の見通し

  • 価格比較分析(2017年)
    • 製品別
    • 地域別
  • 主な潜在顧客
    • 地域別の主要潜在顧客
  • 主要ディストリビューター分析
  • バイオプロセスアナライザーのセグメント分析と概要
  • 技術的進歩
  • 主要な合併・買収

第6章 市場分析および予測:製品別、2016-2026年

  • イントロダクション
  • 主な発見/開発
  • 市場価値予測
    • 上流製品
    • 下流製品
  • 市場の魅力度分析

第7章 市場分析および予測:アプリケーション別、2016-2026年

  • イントロダクション
  • 主な調査結果/展開
  • 市場価値予測
    • 抗生物質
    • モノクローナル抗体
    • 組換えタンパク質
    • プロバイオティクス
    • その他
  • 市場の魅力度分析

第8章 市場分析および予測:エンドユーザー別、2016-2026年

  • イントロダクション
  • 主な調査結果/展開
  • 市場価値予測
    • バイオ医薬品企業
    • 医薬品製造受託機関(CMO)
    • 医薬品開発業務受託機関(CRO)
    • 学術研究機関
    • 食品業界
    • その他
  • 市場の魅力度分析

第9章 市場分析および予測:地域別

  • 主な所見
  • 市場価値予測、地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力度分析

第10章 北米

第11章 欧州

第12章 アジア太平洋

第13章 ラテンアメリカ

第14章 中東・アフリカ

第15章 競合情勢

  • 市場参入企業 - 競合マトリックス(企業の階層と規模別)
  • 企業別市場シェア分析(2016年)
  • 市場勢力分析
    • 地域別
    • 製品別
  • 競争力のある事業戦略
  • 会社概要
    • GE Healthcare
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Sartorius Stedim Biotech
    • Merck KGaA
    • Eppendorf AG
    • F. Hoffmann-La Roche Ltd.
    • Nova Biomedicals
    • Lonza
    • Becton, Dickinson and Company
図表

List of Tables

  • Table 01: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016-2026
  • Table 02: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Products, 2016-2026
  • Table 03: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Products, 2016-2026
  • Table 04: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016-2026
  • Table 05: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) & Volume (Units) Forecast, by End-user, 2016-2026
  • Table 06: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Region, 2016-2026
  • Table 07: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016-2026
  • Table 08: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Product, 2016-2026
  • Table 09: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Product, 2016-2026
  • Table 10: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016-2026
  • Table 11: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 12: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country, 2016-2026
  • Table 13: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016-2026
  • Table 14: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Product, 2016-2026
  • Table 15: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Product, 2016-2026
  • Table 16: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016-2026
  • Table 17: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 18: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 19: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016-2026
  • Table 20: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Products, 2016-2026
  • Table 21: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Products, 2016-2026
  • Table 22: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016-2026
  • Table 23: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 24: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 25: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016-2026
  • Table 26: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Products, 2016-2026
  • Table 27: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Products, 2016-2026
  • Table 28: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016-2026
  • Table 29: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 30: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 31: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016-2026
  • Table 32: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Products, 2016-2026
  • Table 33: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Products, 2016-2026
  • Table 34: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016-2026
  • Table 35: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 36: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026

List of Figures

  • Figure 01: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
  • Figure 02: Global Biopharmaceutical Fermentation Systems
  • Figure 03: Top Three Trends
  • Figure 04: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 05: Global Market Value Share, by Product (2017)
  • Figure 06: Global Market Value Share, by Application (2017)
  • Figure 07: Global Market Value Share, by End-user (2017)
  • Figure 08: Global Market Value Share, by Region (2017)
  • Figure 09: Global Biopharmaceutical Fermentation System Market, by Key Customers and Region (2017)
  • Figure 10: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 11: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Upstream Products, 2017 and 2026
  • Figure 12: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, Downstream Products, 2017 and 2026
  • Figure 13: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Bioreactors/Fermenters, 2016-2026
  • Figure 14: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Bioprocess Analyzers, 2016-2026
  • Figure 15: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Culture Monitoring Devices, 2016-2026
  • Figure 16: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Media & Culture Preparation, 2016-2026
  • Figure 17: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Culture Media, Buffers & Inducers, 2016-2026
  • Figure 18: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Others, 2016-2026
  • Figure 19: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Filtration & Separation, 2016-2026
  • Figure 20: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Chromatography, 2016-2026
  • Figure 21: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Consumables & Accessories, 2016-2026
  • Figure 22: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Others, 2016-2026
  • Figure 23: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Upstream Products, 2018-2026
  • Figure 24: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Downstream Products, 2018-2026
  • Figure 25: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 26: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Antibiotics, 2016-2026
  • Figure 27: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Monoclonal Antibodies, 2016-2026
  • Figure 28: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Recombinant Proteins, 2016-2026
  • Figure 29: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Probiotics, 2016-2026
  • Figure 30: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016-2026
  • Figure 31: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2018-2026
  • Figure 32: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 33: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biopharmaceutical Companies, 2016-2026
  • Figure 34: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by CMOs, 2016-2026
  • Figure 35: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by CDOs, 2016-2026
  • Figure 36: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Academic Research Institutes, 2016-2026
  • Figure 37: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Food Industry, 2016-2026
  • Figure 38: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016-2026
  • Figure 39: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 40: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Region, 2017 and 2026
  • Figure 41: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Region, 2018-2026
  • Figure 42: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 43: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 44: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Upstream Product, 2017 and 2026
  • Figure 45: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Upstream Product, 2018 - 2026
  • Figure 46: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Downstream Product, 2017 and 2026
  • Figure 47: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Downstream Product, 2018 - 2026
  • Figure 48: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 49: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2018 -2026
  • Figure 50: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 51: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 52: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country, 2017 and 2026
  • Figure 53: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country, 2018-2026
  • Figure 54: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 55: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 56: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Upstream Product, 2017 and 2026
  • Figure 57: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Upstream Product, 2018 - 2026
  • Figure 58: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Downstream Product, 2017 and 2026
  • Figure 59: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Downstream Product, 2018 - 2026
  • Figure 60: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 61: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2018 -2026
  • Figure 62: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 63: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 64: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 65: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 66: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 67: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 68: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Upstream Products, 2017 and 2026
  • Figure 69: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Upstream Products, 2018-2026
  • Figure 70: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Downstream Products, 2017 and 2026
  • Figure 71: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Downstream Products, 2018- 2026
  • Figure 72: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 73: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2018-2026
  • Figure 74: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 75: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 76: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 77: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 78: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 79: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 80: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Upstream Products, 2017 and 2026
  • Figure 81: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Upstream Products, 2018-2026
  • Figure 82: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Downstream Products, 2017 and 2026
  • Figure 83: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Downstream Products, 2018-2026
  • Figure 84: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 85: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2018-2026
  • Figure 86: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 87: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 88: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 89: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 90: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 91: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 92: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Upstream Products, 2017 and 2026
  • Figure 93: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Upstream Products, 2018-2026
  • Figure 94: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Downstream Products, 2017 and 2026
  • Figure 95: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Downstream Products, 2018-2026
  • Figure 96: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 97: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2018-2026
  • Figure 98: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 99: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 100: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 101: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 101: Market Footprint Analysis, by Product (Upstream Products)
  • Figure 102: Market Footprint Analysis, by Product (Downstream Products)
  • Figure 103: Global Biopharmaceutical Fermentation Systems Market Share, by Company, 2017
目次

Title:
Biopharmaceutical Fermentation Systems Market (Product - Upstream Products ( Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, Other Upstream Products), Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, Other Downstream Products); Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics; End use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, Food Industry) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026.

Global Biopharmaceutical Fermentation Systems Market: Overview

This report analyzes the global biopharmaceutical fermentation systems market in terms of its current and future scenario. Microbial cell systems have been in use for biopharmaceutical production since the introduction of recombinant insulin. Ease of gene translation and bioproduction process has contributed to the significant adoption of microbial systems in biopharmaceutical production. Rise in research and development activities, technological advancements, increase in awareness about products, and new product launches are some of the factors likely to drive the biopharmaceutical fermentation systems market in the near future.

This report on the global biopharmaceutical fermentation systems market comprises an elaborate executive summary, including a market snapshot that provides information about various segments of the market. The report also provides information and data analysis of the global market with respect to its segments based on product, application, end-user, and geography. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. In addition, the section comprises a competitive matrix and company profiles with a business overview to project the competitive landscape of the market. It also provides market attractiveness analysis in terms of geography, and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario prevailing in the biopharmaceutical fermentation systems market.

Global Biopharmaceutical Fermentation Systems Market: Key Segments

Based on product, the global biopharmaceutical fermentation systems market has been segmented into upstream products ( fermenters, bioprocess analyzers, process monitoring devices, culture & media preparation, culture media, buffers & inducers, other upstream products) and downstream products (filtration & separation systems, chromatography, consumables & accessories, and other downstream products). In terms of application, the market has been classified into recombinant proteins, monoclonal antibodies, antibiotics, probiotics, and others. Based on end-user, the market has been segmented into biopharmaceutical companies, contract manufacturing organizations, contract research organizations, academic research institutes, food industry, and others. The global biopharmaceutical fermentation systems market has been analyzed based on technology trends, expenditure on emerging technologies, and presence of key players in the region. Market size and forecast for each of these segments have been provided for the period of 2016 to 2026, along with their respective CAGR for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Biopharmaceutical Fermentation Systems Market: Regional Outlook

In terms of region, the global biopharmaceutical fermentation systems market has been categorized into five major regions and key countries in these regions: North America (the U.S., Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC, South Africa, Israel, and Rest of Middle East & Africa). Market size and forecast for each of these regions and their key countries have been provided for the period from 2016 to 2026, along with their respective CAGR for the forecast period 2018-2026, considering 2017 as the base year. This report also covers the competitive scenario of the market in these regions.

Companies Mentioned in Report

The report profiles major players operating in the global biopharmaceutical fermentation systems market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in this report are GE Healthcare, Thermo Fisher Scientific Inc., Danaher Corporation, Sartorius StedimBiotech, Merck KGaA, Eppendorf AG, F. Hoffmann-La Roche Ltd., Nova Biomedicals, Lonza, and Becton, and Dickinson and Company.

The global biopharmaceutical fermentation systems market has been segmented as follows:

Biopharmaceutical Fermentation Systems Market, by Product

  • Upstream Products
    • Fermenters
    • Bioprocess Analyzers
    • Process Monitoring Devices
    • Culture & Media Preparation
    • Culture Media, Buffers & Inducers
    • Other Upstream Products
  • Downstream Products
    • Filtration & Separation Systems
    • Chromatography
    • Consumables & Accessories
    • Other Downstream Products

Biopharmaceutical Fermentation Systems Market, by Application

  • Recombinant Proteins
  • Monoclonal Antibodies
  • Antibiotics
  • Probiotics
  • Others (Amino Acids, Enzymes, Polysaccharides, etc.)

Biopharmaceutical Fermentation Systems Market, by End-user

  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations
  • Contract Research Organizations
  • Academic Research Institutes
  • Food Industry
  • Others

Biopharmaceutical Fermentation Systems Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia & New Zealand
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Biopharmaceutical Fermentation Systems Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
    • 4.3.4. Key Trends
  • 4.4. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, 2016-2026
    • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.5. Porter's Five Force Analysis

5. Market Outlook

  • 5.1. Price Comparison Analysis (2017)
    • 5.1.1. By Product
    • 5.1.2. By Region
  • 5.2. Key Potential Customers
    • 5.2.1. Key Potential Customers by Region
  • 5.3. Key Distributor Analysis
  • 5.4. Bioprocess Analyzers Segment Analysis & Overview
  • 5.5.Technological Advancements
  • 5.6.Key Mergers & Acquisitions

6. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2016-2026
    • 6.3.1. Upstream Products
      • 6.3.1.1. Bioreactors/Fermenters
      • 6.3.1.2. Bioprocess Analyzers
      • 6.3.1.3. Process Monitoring Systems
      • 6.3.1.4. Media & Culture Preparation
      • 6.3.1.5. Culture Media, Buffers & Inducers
      • 6.3.1.6. Other Upstream Products
    • 6.3.2. Downstream Products
      • 6.3.2.1. Filtration & Separation
      • 6.3.2.2. Chromatography
      • 6.3.2.3. Consumables & Accessories
      • 6.3.2.4. Other Downstream Products
  • 6.4. Market Attractiveness, by Product

7. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2016-2026
    • 7.3.1. Antibiotics
    • 7.3.2. Monoclonal Antibodies
    • 7.3.3. Recombinant Proteins
    • 7.3.4. Probiotics
    • 7.3.5. Others
  • 7.4. Market Attractiveness, by Application

8. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, by End-users

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-User, 2016-2026
    • 8.3.1. Biopharmaceutical Companies
    • 8.3.2. Contract Manufacturing Organizations
    • 8.3.3. Contract Research Organizations
    • 8.3.4. Academic Research Institutes
    • 8.3.5. Food Industry
    • 8.3.6. Others
  • 8.4. Market Attractiveness, by End-User

9. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness, by Region

10. North America Biopharmaceutical Fermentation Systems Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2016-2026
    • 10.2.1. Upstream Products
      • 10.2.1.1. Bioreactors/Fermenters
      • 10.2.1.2. Bioprocess Analyzers
      • 10.2.1.3. Process Monitoring Systems
      • 10.2.1.4. Media & Culture Preparation
      • 10.2.1.5. Culture Media, Buffers & Inducers
      • 10.2.1.6. Other Upstream Products
    • 10.2.2. Downstream Products
      • 10.2.2.1. Filtration & Separation
      • 10.2.2.2. Chromatography
      • 10.2.2.3. Consumables & Accessories
      • 10.2.2.4. Other Downstream Products
  • 10.3. Market Value Forecast, by Application, 2016-2026
    • 10.3.1. Antibiotics
    • 10.3.2. Monoclonal Antibodies
    • 10.3.3. Recombinant Proteins
    • 10.3.4. Probiotics
    • 10.3.5. Others
  • 10.4. Market Value Forecast, by End-users, 2016-2026
    • 10.4.1. Biopharmaceutical Companies
    • 10.4.2. Contract Manufacturing Organizations
    • 10.4.3. Contract Research Organizations
    • 10.4.4. Academic Research Institutes
    • 10.4.5. Food Industry
    • 10.4.6. Others
  • 10.5. Market Value Forecast, by Country, 2016-2026
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Biopharmaceutical Fermentation Systems Market Analysis and Forecast

  • 11.1.Introduction
    • 11.1.1. Key Findings
  • 11.2.Market Value Forecast, by Product, 2016-2026
    • 11.2.1. Upstream Products
      • 11.2.1.1. Bioreactors Fermenters
      • 11.2.1.2. Bioprocess Analyzers
      • 11.2.1.3. Process Monitoring Systems
      • 11.2.1.4. Media & Culture Preparation
      • 11.2.1.5. Culture Media, Buffers & Inducers
      • 11.2.1.6. Other Upstream Products
    • 11.2.2. Downstream Products
      • 11.2.2.1. Filtration & Separation
      • 11.2.2.2. Chromatography
      • 11.2.2.3. Consumables & Accessories
      • 11.2.2.4. Other Downstream Products
  • 11.3.Market Value Forecast, by Application, 2016-2026
    • 11.3.1. Antibiotics
    • 11.3.2. Monoclonal Antibodies
    • 11.3.3. Recombinant Proteins
    • 11.3.4. Probiotics
    • 11.3.5. Others
  • 11.4.Market Value Forecast, by End-users, 2016-2026
    • 11.4.1. Biopharmaceutical Companies
    • 11.4.2. Contract Manufacturing Organizations
    • 11.4.3. Contract Research Organizations
    • 11.4.4. Academic Research Institutes
    • 11.4.5. Food Industry
    • 11.4.6. Others
  • 11.5.Market Value Forecast, by Country, 2016-2026
    • 11.5.1. Germany
    • 11.5.2. France
    • 11.5.3. U.K.
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6.Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Application
    • 11.6.3. By End-users
    • 11.6.4. By Country

12. Asia Pacific Biopharmaceutical Fermentation Systems Market Analysis and Forecast

  • 12.1.Introduction
    • 12.1.1. Key Findings
  • 12.2.Market Value Forecast, by Product, 2016-2026
    • 12.2.1. Upstream Products
      • 12.2.1.1. Bioreactors/Fermenters
      • 12.2.1.2. Bioprocess Analyzers
      • 12.2.1.3. Process Monitoring Systems
      • 12.2.1.4. Media & Culture Preparation
      • 12.2.1.5. Culture Media, Buffers & Inducers
      • 12.2.1.6. Other Upstream Products
    • 12.2.2. Downstream Products
      • 12.2.2.1. Filtration & Separation
      • 12.2.2.2. Chromatography
      • 12.2.2.3. Consumables & Accessories
      • 12.2.2.4. Other Downstream Products
  • 12.3.Market Value Forecast, by Application, 2016-2026
    • 12.3.1. Antibiotics
    • 12.3.2. Monoclonal Antibodies
    • 12.3.3. Recombinant Proteins
    • 12.3.4. Probiotics
    • 12.3.5. Others
  • 12.4.Market Value Forecast, by End-users, 2016-2026
    • 12.4.1. Biopharmaceutical Companies
    • 12.4.2. Contract Manufacturing Organizations
    • 12.4.3. Contract Research Organizations
    • 12.4.4. Academic Research Institutes
    • 12.4.5. Food Industry
    • 12.4.6. Others
  • 12.5.Market Value Forecast, by Country, 2016-2026
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6.Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Application
    • 12.6.3. By End-users
    • 12.6.4. By Country

13. Latin America Biopharmaceutical Fermentation Systems Market Analysis and Forecast

  • 13.1.Introduction
    • 13.1.1. Key Findings
  • 13.2.Market Value Forecast, by Product, 2016-2026
    • 13.2.1. Upstream Products
      • 13.2.1.1. Bioreactors/Fermenters
      • 13.2.1.2. Bioprocess Analyzers
      • 13.2.1.3. Process Monitoring Systems
      • 13.2.1.4. Media & Culture Preparation
      • 13.2.1.5. Culture Media, Buffers & Inducers
      • 13.2.1.6. Other Upstream Products
    • 13.2.2. Downstream Products
      • 13.2.2.1. Filtration & Separation
      • 13.2.2.2. Chromatography
      • 13.2.2.3. Consumables & Accessories
      • 13.2.2.4. Other Downstream Products
  • 13.3.Market Value Forecast, by Application, 2016-2026
    • 13.3.1. Antibiotics
    • 13.3.2. Monoclonal Antibodies
    • 13.3.3. Recombinant Proteins
    • 13.3.4. Probiotics
    • 13.3.5. Others
  • 13.4.Market Value Forecast, by End-users, 2016-2026
    • 13.4.1. Biopharmaceutical Companies
    • 13.4.2. Contract Manufacturing Organizations
    • 13.4.3. Contract Research Organizations
    • 13.4.4. Academic Research Institutes
    • 13.4.5. Food Industry
    • 13.4.6. Others
  • 13.5.Market Value Forecast, by Country, 2016-2026
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6.Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Application
    • 13.6.3. By End-Users
    • 13.6.4. By Country

14. Middle East & Africa Biopharmaceutical Fermentation Systems Market Analysis and Forecast

  • 14.1.Introduction
    • 14.1.1. Key Findings
  • 14.2.Market Value Forecast, by Product, 2016-2026
    • 14.2.1. Upstream Products
      • 14.2.1.1. Bioreactors/Fermenters
      • 14.2.1.2. Bioprocess Analyzers
      • 14.2.1.3. Process Monitoring Systems
      • 14.2.1.4. Media & Culture Preparation
      • 14.2.1.5. Culture Media, Buffers & Inducers
      • 14.2.1.6. Other Upstream Products
    • 14.2.2. Downstream Products
      • 14.2.2.1. Filtration & Separation
      • 14.2.2.2. Chromatography
      • 14.2.2.3. Consumables & Accessories
      • 14.2.2.4. Other Downstream Products
  • 14.3.Market Value Forecast, by Application, 2016-2026
    • 14.3.1. Antibiotics
    • 14.3.2. Monoclonal Antibodies
    • 14.3.3. Recombinant Proteins
    • 14.3.4. Probiotics
    • 14.3.5. Others
  • 14.4.Market Value Forecast, by End-users, 2016-2026
    • 14.4.1. Biopharmaceutical Companies
    • 14.4.2. Contract Manufacturing Organizations
    • 14.4.3. Contract Research Organizations
    • 14.4.4. Academic Research Institutes
    • 14.4.5. Food Industry
    • 14.4.6. Others
  • 14.5.Market Value Forecast, by Country, 2016-2026
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6.Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Application
    • 14.6.3. By End-users
    • 14.6.4. By Country

15. Competition Landscape

  • 15.1.Market Player - Competition Matrix (By Tier and Size of Companies)
  • 15.2.Market Share Analysis, by Company (2016)
  • 15.3.Market Footprint Analysis
    • 15.3.1. By Region
    • 15.3.2. By Product
  • 15.4. Competitive Business Strategies
  • 15.5. Company Profiles
    • 15.5.1. GE Healthcare
      • 15.5.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.5.1.2. Company Financials
      • 15.5.1.3. Growth Strategies
      • 15.5.1.4. Recent Events
      • 15.5.1.5. SWOT Analysis
    • 15.5.2. Thermo Fisher Scientific Inc.
      • 15.5.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.5.2.2. Company Financials
      • 15.5.2.3. Growth Strategies
      • 15.5.2.4. Recent Events
      • 15.5.2.5. SWOT Analysis
    • 15.5.3. Danaher Corporation
      • 15.5.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.5.3.2. Company Financials
      • 15.5.3.3. Growth Strategies
      • 15.5.3.4. Recent Events
      • 15.5.3.5. SWOT Analysis
    • 15.5.4. Sartorius Stedim Biotech
      • 15.5.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.5.4.2. Company Financials
      • 15.5.4.3. Growth Strategies
      • 15.5.4.4. Recent Events
      • 15.5.4.5. SWOT Analysis
    • 15.5.5. Merck KGaA
      • 15.5.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.5.5.2. Company Financials
      • 15.5.5.3. Growth Strategies
      • 15.5.5.4. Recent Events
      • 15.5.5.5. SWOT Analysis
    • 15.5.6. Eppendorf AG
      • 15.5.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.5.6.2. Company Financials
      • 15.5.6.3. Growth Strategies
      • 15.5.6.4. Recent Events
      • 15.5.6.5. SWOT Analysis
    • 15.5.7. F. Hoffmann-La Roche Ltd.
      • 15.5.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.5.7.2. Company Financials
      • 15.5.7.3. Growth Strategies
      • 15.5.7.4. Recent Events
      • 15.5.7.5. SWOT Analysis
    • 15.5.8. Nova Biomedicals
      • 15.5.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.5.8.2. Growth Strategies
      • 15.5.8.3. Recent Events
      • 15.5.8.4. SWOT Analysis
    • 15.5.9. Lonza
      • 15.5.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.5.9.2. Company Financials
      • 15.5.9.3. Growth Strategies
      • 15.5.9.4. Recent Events
      • 15.5.9.5. SWOT Analysis
    • 15.5.10. Becton, Dickinson and Company
      • 15.5.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.5.10.2. Company Financials
      • 15.5.10.3. Growth Strategies
      • 15.5.10.4. Recent Events
      • 15.5.10.5. SWOT Analysis
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.